Semaglutide biosimilar(Geropharm)

N/A

Report date: 2025/05/15 20:00:08

Base Information

Drug NameSemaglutide biosimilar(Geropharm)

Drug Alias NameGP40221GP-40221

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian Federation

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGeropharm

China Registration ClassN/A

Active CompaniesGeropharm

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeA10BJ06